Pick's disease

Advances in Experimental Medicine and Biology

Volumn 724, Issue , 2012, Pages 300-316

  Takeda, Naoya ^a   Kishimoto, Yuki ^a   Yokota, Osamu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TAR DNA BINDING PROTEIN; TAU PROTEIN;

AGNOSIA; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APRAXIA; ARGYROPHILIC GRAIN DISEASE; ARTICLE; BASOPHILIC INCLUSION BODY DISEASE; BRAIN DISEASE; CELL NUCLEUS INCLUSION BODY; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DIFFUSE LEWY BODY DISEASE; DISEASE DURATION; FRONTOTEMPORAL DEMENTIA; GENE; GRN GENE; HISTOPATHOLOGY; HUMAN; MAPT GENE; MUTATIONAL ANALYSIS; NEUROFIBRILLARY TANGLE; NEURONAL INTERMEDIATE FILAMENT INCLUSION BODY DISEASE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; SEMANTIC DEMENTIA; SPEECH DISORDER; VCP GENE; CLASSIFICATION; FRONTAL LOBE; METABOLISM; PATHOLOGY; REVIEW; TEMPORAL LOBE;

FRONTAL LOBE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; PICK DISEASE OF THE BRAIN; TAU PROTEINS; TEMPORAL LOBE;

EID: 84859508463     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0653-2_23     Document Type: Article

References (84)

1. Pick A. Ueber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wochenschr 1892; 17: 165-167.
2. Alzheimer A. Uber eigenartige Krankheitfalle des spatern Alters. Z Ges Neurol Psychiatr 1911; 4: 356-385.
3. Onari K, Spatz H. Anatomische Beitrage zur Lehre vonpickschenumschriebenen GroBhirnrinden Atrophie (Picksche Krankheit). Z Ges Neurol Psychiatr 1926; 101:470-511.
4. Cummings JL, Duchen LW. Kluver-Bucy syndrome in Pick disease: clinical and pathologic correlations. Neurology 1981; 31:1415-1422.
5. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416-418.
6. Neary D, Snowden JS, Gustafson L et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546-1554.
7. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989; 112:1171-1192.
8. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10:333-359.
9. Braak H, Braak E. Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 1987; 76:124-127.
10. Munoz-Garcia D, Ludwin SK. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural and immunocytochemical comparative study. Ann Neurol 1984; 16:467-480.
11. Cairns NT, Perry RH, Jaros E et al. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003; 341:177-180.
12. Josephs KA, Holton JL, Rossor MN et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003; 126:2291-2303.
13. Arai T, Hasegawa M, Akiyama H et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351:602-611.
14. Neumann M, Sampathu DM, Kwong LK et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314:130-133.
15. Jackson M, Lennox G, Lowe J. Motor neuron disease-inclusion dementia. Neurodegeneration 1996; 5:339-350.
16. Cairns NJ, Bigio EH, Mackenzie IRet al. Neuropathologic diagnostic andnosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol 2007; 114:5-22.
17. Mackenzie IR, Neumann M, Bigio EH et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 2009; 117:15-18.
18. Cairns NJ, Grossman M, Arnold SE et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004; 63:1376-1384.
19. Munoz DG, Neumann M, Kusaka H et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 2009; 118:617-627.
20. Neumann M, Roeber S, Kretzschmar HA et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 2009; 118:605-616.
21. Knopman DS, Mastri AR, Frey WH 2nd et al. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990; 40:251-256.
22. Mackenzie IR, Shi J, Shaw CL et al. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol 2006; 112:551-559.
23. Munoz DG, Dickson DW, Bergeron C et al. The neuropathology and biochemistry of frontotemporal dementia. Ann Neurol 2003; 54 Suppl 5:s24-s28.
24. Josephs KA, Holton JL, Rossor MN et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004; 30:369-373.
25. Forman MS, Farmer J, Johnson JK et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59:952-962.
26. Ikeda K. Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester Group. Neuropathology 2000; 20:76-82.
27. Mackenzie IR, Neumann M, Bigio EH et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010; 119:1-4.
28. Mackenzie IR, Foti D, Woulfe J et al. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 2008; 131:1282-1293.
29. Neumann M, Rademakers R, Roeber S et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009; 132:2922-2931.
30. Frank S, Tolnay M. Frontotemporal lobar degeneration: toward the end of confusion. Acta Neuropathol 2009; 118:629.
31. Amador-Ortiz C, Lin WL, Ahmed Z et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007; 61:435-445.
32. Arai T, Mackenzie IR, Hasegawa M et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2009; 117:125-136.
33. Higashi S, Iseki E, Yamamoto R et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 2007; 1184:284-294.
34. Nakashima-Yasuda H, Uryu K et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 2007; 114:221-229.
35. Yokota O, Davidson Y, Arai T et al. Effect of topographical distribution of alpha-synuclein pathology on TDP-43 accumulation in Lewy body disease. Acta Neuropathol 2010, in press.
36. Uryu K, Nakashima-Yasuda H, Forman MS et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 2008; 67:555-564.
37. Hasegawa M, Arai T, Akiyama H et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain2007; 130:1386-1394.
38. Geser F, Winton MJ, Kwong LK et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 2008; 115(1):133-145.
39. Fujishiro H, Uchikado H, Arai T et al. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease. Acta Neuropathol 2009; 117:151-158.
40. Yokota O, Davidson Y, Bigio EH et al. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 2010; 120:55-66.
41. Geser F, Martinez-Lage M, Kwong LK et al. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.JNeurol 2009; 256(8):1205-1214.
42. Chen-Plotkin AS, Lee VM, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol 2010; 6(4):211-220.
43. Josephs KA, Whitwell JL, Knopman DS et al. Abnormal TDP-43 immunoreactivity in AD modifiesclinicopathologic and radiologic phenotype. Neurology 2008; 70:1850-1857.
44. Ikeda M, Ishikawa T, Tanabe H. Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2004; 17:265-268.
45. Yokota O, Sasaki K, Fujisawa Y et al. Frequency of early and late-onset dementias in a Japanese memory disorders clinic. Eur J Neurol 2005; 12:782-790.
46. Hodges JR, Davies RR, Xuereb JH et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56:399-406.
47. Lipton AM, White CL 3rd, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol 2004; 108:379-385.
48. Kertesz A, McMonagle P, Blair M et al. The evolution and pathology of frontotemporal dementia. Brain 2005; 128:1996-2005.
49. Shi J, Shaw CL, Du Plessis D et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol 2005; 110:501-512.
50. Yokota O, Tsuchiya K, Arai T et al. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol 2009; 117: 429-444.
51. Snowden JS, Pickering-Brown SM, Mackenzie IR et al. Progranulin gene mutations associated with frontotemporal dementia and progressive nonfluent aphasia. Brain 2006; 129:3091-3102.
52. King ME, Ghoshal N, Wall JS et al. Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments. Am J Pathol 2001; 158(4):1481-1490.
53. Odawara T, Iseki E, Kanai A et al. Clinicopathological study of two subtypes of Pick's disease in Japan. Dement Geriatr Cogn Disord 2003; 15:19-25.
54. Davies RR, Hodges JR, Kril JJ et al. The pathological basis of semantic dementia. Brain 2005; 128: 1984-1995.
55. Godbolt AK, Josephs KA, Revesz T et al. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Arch Neurol 2005; 62:1097-1101.
56. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999; 14:674-780.
57. Paviour DC, Lees AJ, Josephs KA et al. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 2004; 127:2441-2451.
58. Graham A, Davies R, Xuereb J et al. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 2005; 128:597-605.
59. Claassen DO, Parisi JE, Giannini C et al. Frontotemporal dementia mimicking dementia with Lewy bodies. Cogn Behav Neurol 2008; 21(3):157-163.
60. Josephs KA, Ahmed Z, Katsuse O et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007; 66:142-151.
61. Pickering-Brown SM, Rollinson S, Du Plessis D et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients withMAPTandnoknownmutations. Brain2008; 131:721-731.
62. Le Berl, Camuzat A, Hannequin D et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 2008; 131:732-746.
63. Fukui T, Sugita K, Kawamura M et al. Primary progressive apraxia in Pick's disease: a clinicopathologic study. Neurology 1996; 47:467-473.
64. Kawamura M, Mochizuki S. Primary progressive apraxia. Neuropathology 1999; 19:249-258.
65. Tsuchiya K, Ikeda K, Uchihara T et al. Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan. Acta Neuropathol 1997; 94:416-424.
66. Grimes DA, Lang AE, Bergeron CB. Dementiaas the most common presentation ofcortical-basal ganglionic degeneration. Neurology 1999; 53:1969-1974.
67. JosephKA, PetersenRC,KnopmanDSetal. Clinicopathological analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66:41-48.
68. Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Current Opinion in Neurology 2008; 21:688-692.
69. Ikeda K, Akiyama H, Iritani S et al. Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review. Acta Neuropathol 1996; 92:534-539.
70. Tsuchiya K, Murayama S, Mitani K et al. Constant and severe involvement of Betz cells in corticobasal degeneration is not consistent with pyramidal signs: a clinicopathological study of ten autopsy cases. Acta Neuropathol 2005; 109:353-366.
71. Boeve BF, Maraganore DM, Parisi JE et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53:795-800.
72. YokotaO, Tsuchiya K, TeradaS et al. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 2008; 115:561-575.
73. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009; 8:270-279.
74. Kusaka H, Matsumoto S, Imai T. An adult-onset case of sporadic motor neuron disease with basophilic inclusions. Acta Neuropathol 1990; 80:660-665.
75. Kusaka H, Matsumoto S, Imai T. Adult-onset motor neuron disease with basophilic intraneuronal inclusion bodies. ClinNeuropathol 1993; 12:215-218.
76. Ishihara K, Araki S, Ihori N et al. An autopsy case of frontotemporal dementia with severe dysarthria and motor neuron disease showing numerous basophilic inclusions. Neuropathology 2006; 26: 447-454.
77. Togo T, Sahara N, Yen SH et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002; 61(6):547-556.
78. Togo T, Cookson N, Dickson DW. Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 2002; 12:45-52.
79. Saito Y, Ruberu NN, Sawabe M et al. Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 2004; 63:911-918.
80. Tsuchiya K, Mitani K, Arai T et al. Argyrophilic grain disease mimicking temporal Pick's disease: a clinical, radiological and pathological study of an autopsy case with a clinical course of 15 years. Acta Neuropathol 2001; 102:195-199.
81. Ishihara K, Araki S, Ihori N et al. Argyrophilic grain disease presenting with frontotemporal dementia: a neuropsychological and pathological study of an autopsied case with presenile onset. Neuropathology 2005; 25:165-170.
82. Ikeda K, Akiyama H, Arai T et al. Clinical aspects of argyrophilic grain disease. Clin Neuropathol 2000; 19:278-284.
83. Togo T, Isojima D, Akatsu H et al. Clinical features of argyrophilic grain disease: a retrospective survey of cases with neuropsychiatric symptoms. Am J Geriatr Psychiatry 2005; 13:1083-1091.
84. Uchikado H, Tsuchiya K, Tominaga I et al. Argyrophilic grain disease clinically mimicking Parkinson's disease with dementia: report of an autopsy case. Brain and Nerve 2004; 56:785-788 (in Japanese with English abstract).